Time In Range

Fast-acting insulin aspart delivered through a hybrid closed-loop insulin delivery system provided similar glycemic outcomes as standard insulin aspart for young children with type 1 diabetes, according to study data.

Adults with type 2 diabetes and a high thyroid-stimulating hormone level are more likely to develop diabetic retinopathy, and low time in range further increases the risk for diabetic retinopathy, according to study data.

Advanced hybrid closed-loop therapy reduces HbA1c and improves time in range among adolescents and young adults with type 1 diabetes, with few serious adverse events, according to findings published in Diabetes Care.

Change in mean glucose may be a better metric for measuring the efficacy of diabetes interventions than HbA1c, time in range and time above range, according to a speaker.

Young children using a hybrid closed-loop insulin delivery system had a greater time in range at 13 weeks compared with those receiving standard care, according to a study published in The New England Journal of Medicine.

Adults with type 1 diabetes spent more time in range with empagliflozin 2.5 mg or 5 mg as an adjunctive therapy to hybrid closed-loop insulin therapy compared with placebo, according to a speaker.

Children with type 1 diabetes who switched from a predictive low-glucose suspend system to automated insulin delivery had improvements in time in range at 1 month that were sustained at 3 months, according to a speaker.

Adults with type 1 diabetes who used an automated insulin delivery system with settings changed by the system instead of a provider had improvements in time in range and HbA1c at 13 weeks, according to a speaker.

HbA1c and continuous glucose monitoring metrics, such as mean glucose and time in range, may not be correlated for some adults with type 2 diabetes, according to study data. The two measures should be used in a complementary manner, according to researchers.

If you’re talking about patient management, there is no question about the value of CGM and time in range, because HbA1c is really not worth anything for management.